Characteristics of the pedigrees analyzed in phase 1, phase 2, and the combined dataset
| No. of affected individuals inpedigree/generation . | No. of pedigrees . | ||
|---|---|---|---|
| Phase 1 . | Phase 2 . | Combined . | |
| 2 | |||
| ––––1 | 71 (10) | 49 (9) | 120 (19) |
| ––––2 | — | 3 | 3 |
| 3 | |||
| ––––1 | 12 | 7 (4) | 19 (4) |
| ––––2 | 15 (5) | 18 (5) | 33 (10) |
| ––––3 | — | 1 | 1 |
| 4 | |||
| ––––1 | 1 | 3 (2) | 4 (2) |
| ––––2 | 3 (3) | 9 (6) | 12 (9) |
| ––––3 | 1 | 1 (1) | 2 (1) |
| 5 | |||
| ––––1 | — | 1 | 1 |
| ––––2 | 1 | 6 (4) | 7 (4) |
| ––––3 | — | 2 (1) | 2 (1) |
| 10: 1 | — | 1 (0) | 1 |
| 12: 4 | 1 (1) | — | 1 (1) |
| Total | 105 (19) | 101 (32) | 206 (51) |
| No. of affected individuals inpedigree/generation . | No. of pedigrees . | ||
|---|---|---|---|
| Phase 1 . | Phase 2 . | Combined . | |
| 2 | |||
| ––––1 | 71 (10) | 49 (9) | 120 (19) |
| ––––2 | — | 3 | 3 |
| 3 | |||
| ––––1 | 12 | 7 (4) | 19 (4) |
| ––––2 | 15 (5) | 18 (5) | 33 (10) |
| ––––3 | — | 1 | 1 |
| 4 | |||
| ––––1 | 1 | 3 (2) | 4 (2) |
| ––––2 | 3 (3) | 9 (6) | 12 (9) |
| ––––3 | 1 | 1 (1) | 2 (1) |
| 5 | |||
| ––––1 | — | 1 | 1 |
| ––––2 | 1 | 6 (4) | 7 (4) |
| ––––3 | — | 2 (1) | 2 (1) |
| 10: 1 | — | 1 (0) | 1 |
| 12: 4 | 1 (1) | — | 1 (1) |
| Total | 105 (19) | 101 (32) | 206 (51) |
The number of pedigrees containing individuals affected with other confirmed B-cell LPDs is shown in parentheses.
— indicates no data.